These effects are likely mediated by TNFα blockade, which reduces local microvascular resistance and enhances blood flow in the superior mesenteric artery (SMA)—a vessel that supplies a substantial portion of the intestines and can be compromised by inflammation observed in Crohn’s disease (CD). This evidence concerns the gene TNF and Crohn disease.